Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Reference106 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Trends in prostate cancer in the United States;Brawley;J Natl Cancer Inst Monogr,2012
3. High-risk prostate cancer in the United States, 1990–2007;Cooperberg;World J Urol,2008
4. Effect of orchiectomy and irradiation on cancer of the prostate;Huggins;Ann Surg,1942
5. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging;Gleason;J Urol,1974
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics;Steroids;2024-10
2. Influence of Solvent Polarity on the Conformer Ratio of Bicalutamide in Saturated Solutions: Insights from NOESY NMR Analysis and Quantum-Chemical Calculations;International Journal of Molecular Sciences;2024-07-28
3. Discovery of a Novel Bifunctional Steroid Analog, YXG-158, as an Androgen Receptor Degrader and CYP17A1 Inhibitor for the Treatment of Enzalutamide-Resistant Prostate Cancer;Journal of Medicinal Chemistry;2023-07-17
4. Current therapy and drug resistance in metastatic castration-resistant prostate cancer;Drug Resistance Updates;2023-05
5. Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer;Pharmacological Research;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3